ArticleJournal of the American Chemical Society2026
Alternative Splicing of a Structured Partner Alters the Folding-Upon-Binding Trajectory of an Intrinsically Disordered Protein.
Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Folding-upon-binding of intrinsically disordered proteins (IDPs) is governed by a complex interplay of kinetic and thermodynamic factors shaped by the structure and conformational dynamics of both binding partners. Alternative splicing offers a natural way to remodel the conformational energy landscape of structured partners, yet how such biologically relevant changes influence the molecular recognition trajectories of interacting IDPs remains poorly understood. Here, using the small GTPase Rac1 and its oncogenic splice variant Rac1b as a model system, we integrate X-ray crystallography, isothermal titration calorimetry (ITC), and nuclear magnetic resonance (NMR) spectroscopy to investigate how the 19-residue insertion in Rac1b alters recognition of the disordered signaling effector POSH. We show that the insertion restricts POSH to partial folding-upon-binding and determine the crystal structure of the POSH-Rac1b complex at 1.77 Å resolution. The structure reveals that POSH stabilizes the otherwise dynamic switch regions of Rac1b in a signaling-competent conformation, while the insertion itself remains dynamic. NMR exchange experiments further delineate the molecular recognition trajectory of POSH upon binding to Rac1b, revealing a folding intermediate characterized by a 5.7-fold slower association rate and a 3-fold faster dissociation rate compared to Rac1. Together, these results demonstrate that the insertion, kinetically and entropically, destabilizes the effector-bound state of Rac1b, directly linking enhanced conformational dynamics to impaired downstream signaling. More broadly, our work illustrates how alternative splicing of folded proteins can reshape folding trajectories, binding kinetics, and thermodynamic landscapes of IDP-mediated interactions, thereby rewiring cellular signaling networks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.